- Effective management of adalimumab|induced acquired hemophilia ...🔍
- Treatment of acquired hemophilia A🔍
- Case Report🔍
- Acquired Hemophilia🔍
- Medline ® Abstract for Reference 78 of 'Acquired hemophilia A 🔍
- Results from the European Acquired Haemophilia Registry 🔍
- Combination Regimen Highly Effective for Acquired Hemophilia A🔍
- Emicizumab Versus Immunosuppression for Acquired Hemophilia Α ...🔍
Combined immunosuppression for acquired hemophilia A
Effective management of adalimumab-induced acquired hemophilia ...
This necessitates a strategic combination of hemostatic agents and immunosuppressive therapy. The approach to hemostatic treatment typically.
Treatment of acquired hemophilia A
Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe bleeding. Management relies on rapid and accurate diagnosis, control of ...
Case Report: Effective management of adalimumab-induced ...
Acquired hemophilia A (AHA) is an autoimmune disorder characterized ... Innovative combined immunosuppressive treatment for AHA: the efficacy and ...
Acquired Hemophilia - Medscape Reference
First-line therapy for inhibitor eradication is with corticosteroids alone or combined with rituximab or cyclophosphamide. Salvage therapy with ...
Medline ® Abstract for Reference 78 of 'Acquired hemophilia A (and ...
Steroids combined with cyclophosphamide resulted in more stable complete remission (70%), defined as inhibitor undetectable, factor VIII more than 70 IU/dL and ...
Results from the European Acquired Haemophilia Registry (EACH2)
Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated, and guidelines recommend immunosuppression as soon as the ...
Combination Regimen Highly Effective for Acquired Hemophilia A
“CyDRi proved to be an attractive option for the immunosuppression of elderly patients with acquired hemophilia A,” the authors wrote in their ...
Emicizumab Versus Immunosuppression for Acquired Hemophilia Α ...
Emicizumab is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ages ...
The Treatment of Acquired Hemophilia with Combination Therapy of ...
We report here an AHA patient who was successfully treated with a combination therapy of immunosuppression and immunoadsorption. A 78-year-old male patient ...
International recommendations on the diagnosis and treatment of ...
212 Citations · Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal Regimen · Acquired Hemophilia A: An Update on the Etiopathogenesis, ...
Acquired Hemophilia A: A Frequently Overlooked Autoimmune ...
Unlike in congenital hemophilia A with inhibitors, in which immune tolerance induction therapy using repetitive infusions of high-dose FVIII ...
A Rare Case of Acquired Hemophilia A in Adolescents and Young ...
Apart from rituximab, useful immunosuppressive agents are mycophenolate mofetil, azathioprine, vincristine, and cyclosporine [5,10,12]. The ...
Acquired hemophilia A: emerging treatment options | JBM
The addition of immune tolerance with FVIII may be considered, although the benefits are unclear, and such treatment significantly increases the ...
Acquired hemophilia A: a single-center study of 165 patients
Immunosuppressive therapies yield remarkably high response rates, with a CR rate exceeding 80%; notably, the regimen containing rituximab exhibits a CR rate of ...
First-line immunosuppressive therapies for acquired hemophilia A
Levesque H. Outcome of acquired hemophilia with steroid combined with cyclophosphamide versus steroid combined with rituximab (CREHA study). http:// ...
results from the European Acquired Haemophilia Registry (EACH2)
Steroids combined with cyclophosphamide ... 47-55. @article{0f703f03436146f3afd73141c093aff9,. title = "Immunosuppression for acquired ...
Cyclophosphamide vs rituximab for eradicating inhibitors in ...
... combination of immunosuppressive ... 32. Simon, B. ∙ Ceglédi, A. ∙ Dolgos, J. ... Combined immunosuppression for acquired hemophilia A: CyDRi is a highly ...
In addition, immunosuppression with steroids is usually effective at reducing inhibitor produc- tion and bringing about a sustained rise in the factor VIII.
Acquired Hemophilia A: An Update on the Etiopathogenesis ... - MDPI
It may also benefit nonresponding or relapsing patients instead of using third-line immunosuppressive regimens or repeated courses of treatments. Moreover, ...
Acquired haemophilia A in a patient with systemic sclerosis treated ...
Treatment of acquired haemophilia A requires urgent control of bleeding and inhibitor eradication by immunosuppression, mainly steroid based, ...